Attana AB (publ) (NGM:ATANA)

Market Cap	12.90M -71.7%
Revenue (ttm)	2.94M -39.4%
Net Income	-12.32M
EPS	n/a
Shares Out	2.58B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,371,680
Open	n/a
Previous Close	0.0060
Day's Range	n/a
52-Week Range	0.0050 - 0.0280
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Attana AB

Attana AB (publ) provides analytical instruments and services for validating, selecting, and optimizing drug candidates primarily in Sweden. The company offers contract research services; in vitro diagnostic tools; analytical instruments; and Attana virus analytics. It serves pharmaceutical and biotechnology companies, and academic institutions. Attana AB (publ) was founded in 2002 and is headquartered in Sollentuna, Sweden.

• Industry: Commercial Physical and Biological Research
• Founded: 2002
• Employees: 6
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: ATANA

Financial Performance

In 2025, Attana AB's revenue was 4.01 million, a decrease of -39.40% compared to the previous year's 6.61 million. Losses were -11.03 million, -13.65% less than in 2024.